Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FCMXX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,499.90 for Stelara 90 mg/ml syringes. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities nationwide.
Stelara is a biologic immunosuppressant medication used to treat various inflammatory and autoimmune conditions. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status and established relationships with the DLA to compete effectively in federal procurement markets. The company's contract portfolio demonstrates consistent success in delivering specialized pharmaceutical products, including biologics, injections, and prescription medications to military health facilities, positioning it as a key distributor of pharmacy services and medical supplies to Defense Department healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FCMXX?
SPE2DB25FCMXX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FCMXX worth?
The government has obligated $32,500 on SPE2DB25FCMXX.
Is contract SPE2DB25FCMXX an order under another contract?
Yes. SPE2DB25FCMXX is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMXX competed?
The extent of competition for SPE2DB25FCMXX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award